Cargando…
Chronic Sulfasalazine Treatment in Mice Induces System x(c) (−) - Independent Adverse Effects
Despite ample evidence for the therapeutic potential of inhibition of the cystine/glutamate antiporter system x(c) (−) in neurological disorders and in cancer, none of the proposed inhibitors is selective. In this context, a lot of research has been performed using the EMA- and FDA-approved drug sul...
Autores principales: | Verbruggen, Lise, Sprimont, Lindsay, Bentea, Eduard, Janssen, Pauline, Gharib, Azzedine, Deneyer, Lauren, De Pauw, Laura, Lara, Olaya, Sato, Hideyo, Nicaise, Charles, Massie, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167035/ https://www.ncbi.nlm.nih.gov/pubmed/34084129 http://dx.doi.org/10.3389/fphar.2021.625699 |
Ejemplares similares
-
Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
por: Bentea, Eduard, et al.
Publicado: (2021) -
Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson’s Disease
por: Deneyer, Lauren, et al.
Publicado: (2018) -
12.3 SYSTEM XC- AS A NOVEL MODULATOR OF CORTICOSTRIATAL NEUROTRANSMISSION
por: Bentea, Eduard, et al.
Publicado: (2018) -
The Proteasome Inhibition Model of Parkinson’s Disease
por: Bentea, Eduard, et al.
Publicado: (2017) -
Cystine–glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice
por: Sprimont, Lindsay, et al.
Publicado: (2021)